Adult high-grade B-cell lymphoma with Burkitt lymphoma signature

Genomic features and potential therapeutic targets

Alyssa Bouska, Chengfeng Bi, Waseem Lone, Weiwei Zhang, Ambreen Kedwaii, Tayla Heavican, Cynthia M. Lachel, Jiayu Yu, Roberto Ferro, Nanees Eldorghamy, Timothy Charles Greiner, Julie Marie Vose, Dennis D. Weisenburger, Randy D. Gascoyne, Andreas Rosenwald, German Ott, Elias Campo, Lisa M. Rimsza, Elaine S. Jaffe, Rita M. Braziel & 12 others Reiner Siebert, Rodney R. Miles, Sandeep Dave, Anupama Reddy, Jan Delabie, Louis M. Staudt, Joo Y. Song, Timothy W. McKeithan, Kai Fu, Michael Green, Wing C. Chan, Javeed Iqbal

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The adult high-grade B-cell lymphomas sharing molecular features with Burkitt lymphoma (BL) are highly aggressivelymphomas with poor clinical outcome. High-resolution structural and functional genomic analysis of adult Burkitt lymphoma (BL) and high-grade B-cell lymphoma with BL gene signature (adult-molecularly defined BL [mBL]) revealed the MYCARF- p53 axis as the primary deregulated pathway. Adult-mBL had either unique or more frequent genomic aberrations (del13q14, del17p, gain8q24, and gain18q21) compared with pediatric-mBL, but shared commonly mutated genes. Mutations in genes promoting the tonic B-cell receptor (BCR)→PI3K pathway (TCF3 and ID3) did not differ by age, whereas effectors of chronic BCR→NF-κB signaling were associated with adult-mBL. A subset of adult-mBL had BCL2 translocation and mutation and elevated BCL2 mRNA and protein expression, but had a mutation profile similar to mBL. These double-hit lymphomas may have arisen from a tumor precursor that acquired both BCL2 and MYC translocations and/or KMT2D(MLL2)mutation. Gain/amplification of MIR17HG and its paralogue loci was observed in 50% of adult-mBL. In vitro studies suggested miR-17∼92's role in constitutive activation of BCR signaling and sensitivity to ibrutinib. Overall integrative analysis identified an interrelated gene network affected by copy number and mutation, leading to disruption of the p53 pathway andtheBCR→PI3Kor NF-κB activation, which can be further exploited in vivo by small-molecule inhibitors for effective therapy in adult-mBL.

Original languageEnglish (US)
Pages (from-to)1819-1831
Number of pages13
JournalBlood
Volume130
Issue number16
DOIs
StatePublished - Oct 19 2017

Fingerprint

Burkitt Lymphoma
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Genes
Cells
Mutation
Chemical activation
Proto-Oncogene Proteins c-bcl-2
B-Lymphocytes
Pediatrics
Therapeutics
Aberrations
Phosphatidylinositol 3-Kinases
Gene Regulatory Networks
Amplification
Tumors
Lymphoma
Messenger RNA
Molecules
Proteins

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Adult high-grade B-cell lymphoma with Burkitt lymphoma signature : Genomic features and potential therapeutic targets. / Bouska, Alyssa; Bi, Chengfeng; Lone, Waseem; Zhang, Weiwei; Kedwaii, Ambreen; Heavican, Tayla; Lachel, Cynthia M.; Yu, Jiayu; Ferro, Roberto; Eldorghamy, Nanees; Greiner, Timothy Charles; Vose, Julie Marie; Weisenburger, Dennis D.; Gascoyne, Randy D.; Rosenwald, Andreas; Ott, German; Campo, Elias; Rimsza, Lisa M.; Jaffe, Elaine S.; Braziel, Rita M.; Siebert, Reiner; Miles, Rodney R.; Dave, Sandeep; Reddy, Anupama; Delabie, Jan; Staudt, Louis M.; Song, Joo Y.; McKeithan, Timothy W.; Fu, Kai; Green, Michael; Chan, Wing C.; Iqbal, Javeed.

In: Blood, Vol. 130, No. 16, 19.10.2017, p. 1819-1831.

Research output: Contribution to journalArticle

Bouska, A, Bi, C, Lone, W, Zhang, W, Kedwaii, A, Heavican, T, Lachel, CM, Yu, J, Ferro, R, Eldorghamy, N, Greiner, TC, Vose, JM, Weisenburger, DD, Gascoyne, RD, Rosenwald, A, Ott, G, Campo, E, Rimsza, LM, Jaffe, ES, Braziel, RM, Siebert, R, Miles, RR, Dave, S, Reddy, A, Delabie, J, Staudt, LM, Song, JY, McKeithan, TW, Fu, K, Green, M, Chan, WC & Iqbal, J 2017, 'Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: Genomic features and potential therapeutic targets', Blood, vol. 130, no. 16, pp. 1819-1831. https://doi.org/10.1182/blood-2017-02-767335
Bouska, Alyssa ; Bi, Chengfeng ; Lone, Waseem ; Zhang, Weiwei ; Kedwaii, Ambreen ; Heavican, Tayla ; Lachel, Cynthia M. ; Yu, Jiayu ; Ferro, Roberto ; Eldorghamy, Nanees ; Greiner, Timothy Charles ; Vose, Julie Marie ; Weisenburger, Dennis D. ; Gascoyne, Randy D. ; Rosenwald, Andreas ; Ott, German ; Campo, Elias ; Rimsza, Lisa M. ; Jaffe, Elaine S. ; Braziel, Rita M. ; Siebert, Reiner ; Miles, Rodney R. ; Dave, Sandeep ; Reddy, Anupama ; Delabie, Jan ; Staudt, Louis M. ; Song, Joo Y. ; McKeithan, Timothy W. ; Fu, Kai ; Green, Michael ; Chan, Wing C. ; Iqbal, Javeed. / Adult high-grade B-cell lymphoma with Burkitt lymphoma signature : Genomic features and potential therapeutic targets. In: Blood. 2017 ; Vol. 130, No. 16. pp. 1819-1831.
@article{6d8e48f70f7e4c9cbdf03475f2e38e23,
title = "Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: Genomic features and potential therapeutic targets",
abstract = "The adult high-grade B-cell lymphomas sharing molecular features with Burkitt lymphoma (BL) are highly aggressivelymphomas with poor clinical outcome. High-resolution structural and functional genomic analysis of adult Burkitt lymphoma (BL) and high-grade B-cell lymphoma with BL gene signature (adult-molecularly defined BL [mBL]) revealed the MYCARF- p53 axis as the primary deregulated pathway. Adult-mBL had either unique or more frequent genomic aberrations (del13q14, del17p, gain8q24, and gain18q21) compared with pediatric-mBL, but shared commonly mutated genes. Mutations in genes promoting the tonic B-cell receptor (BCR)→PI3K pathway (TCF3 and ID3) did not differ by age, whereas effectors of chronic BCR→NF-κB signaling were associated with adult-mBL. A subset of adult-mBL had BCL2 translocation and mutation and elevated BCL2 mRNA and protein expression, but had a mutation profile similar to mBL. These double-hit lymphomas may have arisen from a tumor precursor that acquired both BCL2 and MYC translocations and/or KMT2D(MLL2)mutation. Gain/amplification of MIR17HG and its paralogue loci was observed in 50{\%} of adult-mBL. In vitro studies suggested miR-17∼92's role in constitutive activation of BCR signaling and sensitivity to ibrutinib. Overall integrative analysis identified an interrelated gene network affected by copy number and mutation, leading to disruption of the p53 pathway andtheBCR→PI3Kor NF-κB activation, which can be further exploited in vivo by small-molecule inhibitors for effective therapy in adult-mBL.",
author = "Alyssa Bouska and Chengfeng Bi and Waseem Lone and Weiwei Zhang and Ambreen Kedwaii and Tayla Heavican and Lachel, {Cynthia M.} and Jiayu Yu and Roberto Ferro and Nanees Eldorghamy and Greiner, {Timothy Charles} and Vose, {Julie Marie} and Weisenburger, {Dennis D.} and Gascoyne, {Randy D.} and Andreas Rosenwald and German Ott and Elias Campo and Rimsza, {Lisa M.} and Jaffe, {Elaine S.} and Braziel, {Rita M.} and Reiner Siebert and Miles, {Rodney R.} and Sandeep Dave and Anupama Reddy and Jan Delabie and Staudt, {Louis M.} and Song, {Joo Y.} and McKeithan, {Timothy W.} and Kai Fu and Michael Green and Chan, {Wing C.} and Javeed Iqbal",
year = "2017",
month = "10",
day = "19",
doi = "10.1182/blood-2017-02-767335",
language = "English (US)",
volume = "130",
pages = "1819--1831",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "16",

}

TY - JOUR

T1 - Adult high-grade B-cell lymphoma with Burkitt lymphoma signature

T2 - Genomic features and potential therapeutic targets

AU - Bouska, Alyssa

AU - Bi, Chengfeng

AU - Lone, Waseem

AU - Zhang, Weiwei

AU - Kedwaii, Ambreen

AU - Heavican, Tayla

AU - Lachel, Cynthia M.

AU - Yu, Jiayu

AU - Ferro, Roberto

AU - Eldorghamy, Nanees

AU - Greiner, Timothy Charles

AU - Vose, Julie Marie

AU - Weisenburger, Dennis D.

AU - Gascoyne, Randy D.

AU - Rosenwald, Andreas

AU - Ott, German

AU - Campo, Elias

AU - Rimsza, Lisa M.

AU - Jaffe, Elaine S.

AU - Braziel, Rita M.

AU - Siebert, Reiner

AU - Miles, Rodney R.

AU - Dave, Sandeep

AU - Reddy, Anupama

AU - Delabie, Jan

AU - Staudt, Louis M.

AU - Song, Joo Y.

AU - McKeithan, Timothy W.

AU - Fu, Kai

AU - Green, Michael

AU - Chan, Wing C.

AU - Iqbal, Javeed

PY - 2017/10/19

Y1 - 2017/10/19

N2 - The adult high-grade B-cell lymphomas sharing molecular features with Burkitt lymphoma (BL) are highly aggressivelymphomas with poor clinical outcome. High-resolution structural and functional genomic analysis of adult Burkitt lymphoma (BL) and high-grade B-cell lymphoma with BL gene signature (adult-molecularly defined BL [mBL]) revealed the MYCARF- p53 axis as the primary deregulated pathway. Adult-mBL had either unique or more frequent genomic aberrations (del13q14, del17p, gain8q24, and gain18q21) compared with pediatric-mBL, but shared commonly mutated genes. Mutations in genes promoting the tonic B-cell receptor (BCR)→PI3K pathway (TCF3 and ID3) did not differ by age, whereas effectors of chronic BCR→NF-κB signaling were associated with adult-mBL. A subset of adult-mBL had BCL2 translocation and mutation and elevated BCL2 mRNA and protein expression, but had a mutation profile similar to mBL. These double-hit lymphomas may have arisen from a tumor precursor that acquired both BCL2 and MYC translocations and/or KMT2D(MLL2)mutation. Gain/amplification of MIR17HG and its paralogue loci was observed in 50% of adult-mBL. In vitro studies suggested miR-17∼92's role in constitutive activation of BCR signaling and sensitivity to ibrutinib. Overall integrative analysis identified an interrelated gene network affected by copy number and mutation, leading to disruption of the p53 pathway andtheBCR→PI3Kor NF-κB activation, which can be further exploited in vivo by small-molecule inhibitors for effective therapy in adult-mBL.

AB - The adult high-grade B-cell lymphomas sharing molecular features with Burkitt lymphoma (BL) are highly aggressivelymphomas with poor clinical outcome. High-resolution structural and functional genomic analysis of adult Burkitt lymphoma (BL) and high-grade B-cell lymphoma with BL gene signature (adult-molecularly defined BL [mBL]) revealed the MYCARF- p53 axis as the primary deregulated pathway. Adult-mBL had either unique or more frequent genomic aberrations (del13q14, del17p, gain8q24, and gain18q21) compared with pediatric-mBL, but shared commonly mutated genes. Mutations in genes promoting the tonic B-cell receptor (BCR)→PI3K pathway (TCF3 and ID3) did not differ by age, whereas effectors of chronic BCR→NF-κB signaling were associated with adult-mBL. A subset of adult-mBL had BCL2 translocation and mutation and elevated BCL2 mRNA and protein expression, but had a mutation profile similar to mBL. These double-hit lymphomas may have arisen from a tumor precursor that acquired both BCL2 and MYC translocations and/or KMT2D(MLL2)mutation. Gain/amplification of MIR17HG and its paralogue loci was observed in 50% of adult-mBL. In vitro studies suggested miR-17∼92's role in constitutive activation of BCR signaling and sensitivity to ibrutinib. Overall integrative analysis identified an interrelated gene network affected by copy number and mutation, leading to disruption of the p53 pathway andtheBCR→PI3Kor NF-κB activation, which can be further exploited in vivo by small-molecule inhibitors for effective therapy in adult-mBL.

UR - http://www.scopus.com/inward/record.url?scp=85032213226&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032213226&partnerID=8YFLogxK

U2 - 10.1182/blood-2017-02-767335

DO - 10.1182/blood-2017-02-767335

M3 - Article

VL - 130

SP - 1819

EP - 1831

JO - Blood

JF - Blood

SN - 0006-4971

IS - 16

ER -